Home > Healthcare > Medical Devices > Surgical Devices > Neurothrombectomy Devices Market
Neurothrombectomy Devices Market Share
- Report ID: GMI7700
- Published Date: Dec 2023
- Report Format: PDF
Neurothrombectomy Devices Market Share
The neurothrombectomy devices industry is consolidated, with key players including Medtronic Plc, Stryker Corporation, Penumbra, Inc., MicroVention, Inc. (Terumo Corporation) and others dominating the market. These companies focus on ongoing product innovation, geographical expansion, and partnerships to secure substantial market shares. For instance, in February 2023, Penumbra, Inc. launched the lightning flash mechanical thrombectomy system following FDA clearance. This innovative system integrates Penumbra's Lightning intelligent aspiration technology, enhanced with dual clot detection algorithms. The Lightning Flash device is specifically designed for the swift removal of substantial blood clots, encompassing venous thrombus and pulmonary emboli. This approval expands the company's product portfolio, positioning it with a competitive edge in the market.
Neurothrombectomy Devices Market Companies
Some of the eminent market participants operating in the neurothrombectomy devices industry include:
- Medtronic Plc
- Stryker Corporation
- Penumbra, Inc.
- Johnson & Johnson
- MicroVention, Inc. (Terumo Corporation)
- Acandis GmbH
- Phenox Inc.(Wallaby Medical)
- Vesalio, LLC
- AngioDynamics, Inc.
- Abbott Laboratories
- Edward Lifesciences Corporation
- Boston Scientific Corporation
Frequently Asked Questions (FAQ) :
Neurothrombectomy Devices Market Scope
